DPP4 and neoplasm: In this study, we performed clinical tests, genetic analysis and validation, and molecular biology experiments to explore the novel loss-of-function p.V486M (c.1456 G>A) mutation in DPP4, which potentially accounts for the extremely high AGLP-1 levels in the proband, and further assessed subsequent glucose and lipid metabolism, as well as tumor markers.